STUDY ON THE FETO-MATERNAL OUTCOME IN SICKLE CELL HEMOGLOBINOPATHY AT A RURAL TERTIARY CARE CENTER IN KERALA

Main Article Content

Dr. Noori Khalid
Dr. Divya S.
Dr. Rejeesh S. Ravi
Dr. Amarpali K. S.

Keywords

Maternal morbidity, Maternal mortality, Perinatal outcome, Perinatal mortality, Sickle cell disease, Vaso-occlusive crisis.

Abstract

Background: In India sickle cell disease is a genetic haematological condition that is common. Pregnancy outcomes can be adversely affected by sickle cell disease as it can exacerbate pregnancy difficulties. The present research was done to study the feto-maternal outcome in sickle cell hemoglobinopathy at a rural tertiary care center in Kerala.


Methods: The retrospective study was done among 28 pregnant women with sickle cell disease or trait who were seen in the department of OBG during the period of Dec 2017 – Nov 2019. Pregnancy outcomes, diagnostic morbidities, and treatments received were estimated using the cross-tabulation approach.For statistical analysis, we utilized SPSS version 25.0.


Results: Total patients suffering from sickle cell disease were 9 (32.1%) and those with sickle cell trait were 19 (67.8%). The commomcomplications seen during the pregnancy were pre-eclampsia (14.2%), postpartum eclampsia (3.5%), pre term labor (17.9%), hypertension (7.1%), IUGR (39.2%) and oligohydramnios (21.4%). Main SCD complication were Anemia (67.8%) blood transfusion (32.1%), UTI (28.5%), bone crisis (10.7%), and vaso-occlusive crisis (3.5%).Common mode of delivery was vaginal (53.5%) whereas 46.4% delivered through C-section. Perinatal outcome observed were postpartum depression and psychosis (7.12%), severe anemia and thrombocytopenia (3.5%), NICU admission (7.12%), shoulder dystocia (3.5%) and mortality (3.5%).


Conclusion: Due to obstetric and medical problems, pregnancy in individuals with sickle cell disease is linked to a higher risk of maternal morbidity and a higher risk of perinatal mortality.

Abstract 141 | PDF Downloads 80

References

1. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364:1343-60.
2. Odièvre MH, Verger E, Silva-Pinto AC, Elion J. Pathophysiological insights in sickle cell disease. Indian J Med Res 2011;134:532-7.
3. Sparkenbaugh E, Pawlinski R. Interplay between coagulation and vascular inflammation in sickle cell disease. British J Haematol 2013;162:3-14.
4. Ugboma H, George I. Sickle cell disease in pregnancy: maternal and fetal outcome in Port Harcourt, Nigeria. British J Medicine Medical Res 2015;7(1):40-4.
5. Bhukhanvala D, Gupte S, Patel A, Shah A, Sorathiya S. Prevalence and hematological profile of βthalassemia and sickle cell anemia in four communities of Surat city. Indian J Human Genetics 2012;18(2):167-71.
6. Elenga N, Adeline A, Balcaen J, Vaz T, Calvez M, Terraz A, et al. Pregnancy in sickle cell disease is a very high-risk situation: an observational study. ObstetGynecolInt 2016;2016.
7. Modi RS, Patel SS, Modi DA, Talesara H. Fetomaternal outcome in sickle cell disease in a tertiary care centre. Int J ReprodContraceptObstetGynecol 2021;10:619-23.
8. Balgir R. Epidemiology, population health genetics and phenotypic diversity of sickle cell disease in India. Internet J BiolAnthropol 2007;1(2):1-26.
9. Feroze M, Aravindan KP. Sickle cell disease in Wayanad, Kerala: gene frequencies and disease characteristics. Nat Med J India 2001;14(5):267-70.
10. Doyle P, et al. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis. Blood 2015;125(21):3316-25.
11. Silva-Pinto AC, Ladeira SOD, Brunetta DM, Santis GC, Angulo IL, Covas DT. Sickle cell disease and pregnancy: analysis of 34 patients followed at the regional blood center of ribeirãopreto, Brazil. RevistaBrasileira de Hematologia e Hemoterapia 2014;36(5):329-33.
12. Wilson NO, Ceesay FK, Hibbert JM, Driss A, Obed SA, Adjei AA, et al. Pregnancy outcomes among patients with sickle cell disease at Korle-Bu Teaching Hospital, Accra, Ghana: retrospective cohort study. Am J Tropical Med Hygiene 2012;86(6):936-42.
13. Ngô C, Kayem G, Habibi A, Benachi A, Goffinet F, Galactéros F, et al. Pregnancy in sickle cell disease: Maternal and fetal outcomes in a population receiving prophylactic partial exchange transfusions. European J ObstGynecol Reproductive Biol 2010;152(2):138-42.
14. Jama FE, Gasem T, Burshaid S, Rahman J, Suleiman SA, Rahman MS. Pregnancy outcome in patients with homozygous sickle cell disease in a university hospital, Eastern Saudi Arabia. Arch GynecolObstet 2009;280(5):793-7.
15. Desai G, Anand A, Shah P, Shah S, Dave K, Bhatt H, et al. Sickle cell disease and pregnancy outcomes: a study of the community-based hospital in a tribal block of Gujarat, India. J Health Population Nutrition 2017;36(1):3.
16. Yu CKH, Stasiowska E, Stephens A, Awogbade M, Davies A. Outcome of pregnancy in sickle cell disease patients attending a combined obstetric and haematology clinic. J ObstGynaecol 2009;29(6):512-6.
17. Orazulike FN, Ijeoma FC. Feto-maternal outcome in patients with sickle cell anaemia at the University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria: a ten year retrospective review. Int J ObstetGynecol 2015;3:54-8.
18. Muganyizi PS, Kidanto H. Sickle cell disease in pregnancy: trend and pregnancy outcomes at a tertiary hospital in Tanzania. PLoS One 2013;8(2):34-8.
19. Modi RS, Patel SS, Modi DA, Talesara H. Fetomaternal outcome in sickle cell disease in a tertiary care centre. Int J Reprod Contracept Obstet Gynecol 2021;10:619-23.
20. D'Couth S, Kalam S. Fetomaternal outcome in sickle cell hemoglobinopathy in a tertiary care centre of North Kerala, India. Int J Reprod Contracept Obstet Gynecol 2017;6:5299-305.